NCT01041456

Brief Summary

The aim of this study is to describe the clinical presentation, indications, and operative treatment as well as assess the morbidity, mortality, and overall performance of revisional GBP after either failed and/or complicated Biliopancreatic Diversion "BPD" for weight loss. With such information, we hope to determine what features might assist us in advancing our knowledge about mechanisms of failure after primary bariatric surgery, mechanism of action of revisional GBP, and performance of revisional GBP through traditional outcome measurements as well as identifying predictors of good or poor outcome after revisional GBP in this specific subpopulation.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
10

participants targeted

Target at below P25 for all trials

Timeline
Completed

Started Mar 2009

Shorter than P25 for all trials

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

March 1, 2009

Completed
5 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

August 1, 2009

Completed
2 months until next milestone

Study Completion

Last participant's last visit for all outcomes

October 1, 2009

Completed
3 months until next milestone

First Submitted

Initial submission to the registry

December 26, 2009

Completed
5 days until next milestone

First Posted

Study publicly available on registry

December 31, 2009

Completed
Last Updated

January 1, 2010

Status Verified

December 1, 2009

Enrollment Period

5 months

First QC Date

December 26, 2009

Last Update Submit

December 31, 2009

Conditions

Keywords

complicated biliopancreatic diversionfailed biliopancreatic diversionrevision gastric bypassconversion bariatric surgeryrevision bariatric surgeryre-operative bariatric surgerymalabsorptive syndromeprotein malnutritionmetabolic bone disease

Outcome Measures

Primary Outcomes (2)

  • Morbidity and mortality

    at discharge, 1 week, 3 weeks, 8 weeks, 3 months, 6 months, 1 year and annually thereafter for up to 8 years

  • Weight loss expressed as Body Mass Index and Percentage of excess weight loss

    at 6 months, 1 year and annually thereafter for up to 8 years

Secondary Outcomes (4)

  • Trend in comorbidities

    at 6 months, 1 year, and annually thereafter for up to 8 years

  • Symptom resolution

    at 6 months, 1 year, and annually thereafter for up to 8 years

  • Length of operative time which is defined as the time duration of operation measured in minutes from the first skin incision to the final closure of the skin incision

    It is measured in minutes from the first skin incision to the final closure of the skin incision at the time of revisional surgery under study. It is a transoperative measure of outcome of the surgery under study

  • Length of Hospital Stay which is a measured of surgical recovery quantified and reported in days. It is a hospital pre-discharge traditional measure of outcome

    It is measured in days from the admission date to the discharge date for the hospitalization pertaining to revisional surgery under study

Study Arms (1)

complicated and/or failed BPD

Eligibility Criteria

Age18 Years - 65 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Patients referred with severe, persistent and/or recurrent metabolic/nutritional complications after open biliopancreatic diversion for clinically severe obesity underwent either laparoscopic or open conversion to Roux-en-Y gastric bypass. Intractability after interdisciplinary optimized medical therapy for metabolic and/or nutritional complications warranted surgical management.

You may qualify if:

  • Patients status post biliopancreatic diversion with any combination of the following severe late complications:
  • Metabolic and/or nutritional BPD-related complications.
  • Excessive weight loss
  • Poor weight loss, either Inadequate initial weight loss or Weight recidivism
  • Intolerable intestinal malabsorptive symptoms without severe malnutrition
  • Undergoing either open or laparoscopic conversion to Roux-en-Y gastric bypass (RYGB) surgery.

You may not qualify if:

  • Any other type of revision or conversion surgery.
  • Adequate response to medical management of metabolic and nutritional complications after previous BPD
  • missing records and/or unreachable patients with scant information for analysis

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

UCSF Fresno Center for Medical Education and Research

Fresno, California, 93701, United States

Location

Related Publications (71)

  • Higa KD, Boone KB, Ho T, Davies OG. Laparoscopic Roux-en-Y gastric bypass for morbid obesity: technique and preliminary results of our first 400 patients. Arch Surg. 2000 Sep;135(9):1029-33; discussion 1033-4. doi: 10.1001/archsurg.135.9.1029.

    PMID: 10982506BACKGROUND
  • Hedley AA, Ogden CL, Johnson CL, Carroll MD, Curtin LR, Flegal KM. Prevalence of overweight and obesity among US children, adolescents, and adults, 1999-2002. JAMA. 2004 Jun 16;291(23):2847-50. doi: 10.1001/jama.291.23.2847.

    PMID: 15199035BACKGROUND
  • McTigue KM, Harris R, Hemphill B, Lux L, Sutton S, Bunton AJ, Lohr KN. Screening and interventions for obesity in adults: summary of the evidence for the U.S. Preventive Services Task Force. Ann Intern Med. 2003 Dec 2;139(11):933-49. doi: 10.7326/0003-4819-139-11-200312020-00013.

    PMID: 14644897BACKGROUND
  • Buchwald H, Avidor Y, Braunwald E, Jensen MD, Pories W, Fahrbach K, Schoelles K. Bariatric surgery: a systematic review and meta-analysis. JAMA. 2004 Oct 13;292(14):1724-37. doi: 10.1001/jama.292.14.1724.

    PMID: 15479938BACKGROUND
  • Christou NV, Sampalis JS, Liberman M, Look D, Auger S, McLean AP, MacLean LD. Surgery decreases long-term mortality, morbidity, and health care use in morbidly obese patients. Ann Surg. 2004 Sep;240(3):416-23; discussion 423-4. doi: 10.1097/01.sla.0000137343.63376.19.

    PMID: 15319713BACKGROUND
  • Adams TD, Gress RE, Smith SC, Halverson RC, Simper SC, Rosamond WD, Lamonte MJ, Stroup AM, Hunt SC. Long-term mortality after gastric bypass surgery. N Engl J Med. 2007 Aug 23;357(8):753-61. doi: 10.1056/NEJMoa066603.

    PMID: 17715409BACKGROUND
  • Sjostrom L, Narbro K, Sjostrom CD, Karason K, Larsson B, Wedel H, Lystig T, Sullivan M, Bouchard C, Carlsson B, Bengtsson C, Dahlgren S, Gummesson A, Jacobson P, Karlsson J, Lindroos AK, Lonroth H, Naslund I, Olbers T, Stenlof K, Torgerson J, Agren G, Carlsson LM; Swedish Obese Subjects Study. Effects of bariatric surgery on mortality in Swedish obese subjects. N Engl J Med. 2007 Aug 23;357(8):741-52. doi: 10.1056/NEJMoa066254.

    PMID: 17715408BACKGROUND
  • Cremieux PY, Buchwald H, Shikora SA, Ghosh A, Yang HE, Buessing M. A study on the economic impact of bariatric surgery. Am J Manag Care. 2008 Sep;14(9):589-96.

    PMID: 18778174BACKGROUND
  • Santry HP, Gillen DL, Lauderdale DS. Trends in bariatric surgical procedures. JAMA. 2005 Oct 19;294(15):1909-17. doi: 10.1001/jama.294.15.1909.

    PMID: 16234497BACKGROUND
  • Flum DR, Khan TV, Dellinger EP. Toward the rational and equitable use of bariatric surgery. JAMA. 2007 Sep 26;298(12):1442-4. doi: 10.1001/jama.298.12.1442. No abstract available.

    PMID: 17895461BACKGROUND
  • Meguid MM, Glade MJ, Middleton FA. Weight regain after Roux-en-Y: a significant 20% complication related to PYY. Nutrition. 2008 Sep;24(9):832-42. doi: 10.1016/j.nut.2008.06.027.

    PMID: 18725080BACKGROUND
  • Nguyen NT. Reoperations and revisions in bariatric surgery. Surg Endosc. 2007 Nov;21(11):1907-8. doi: 10.1007/s00464-007-9572-6. Epub 2007 Sep 8. No abstract available.

    PMID: 17828427BACKGROUND
  • http://www.asbs.org/htm/Private/resolution.html. American Society of Metabolic and Bariatric Surgeons.

    BACKGROUND
  • Davies DJ, Baxter JM, Baxter JN. Nutritional deficiencies after bariatric surgery. Obes Surg. 2007 Sep;17(9):1150-8. doi: 10.1007/s11695-007-9208-x.

    PMID: 18074487BACKGROUND
  • Brolin RE, Leung M. Survey of vitamin and mineral supplementation after gastric bypass and biliopancreatic diversion for morbid obesity. Obes Surg. 1999 Apr;9(2):150-4. doi: 10.1381/096089299765553395.

    PMID: 10340768BACKGROUND
  • Scopinaro N, Gianetta E, Civalleri D, Bonalumi U, Bachi V. Bilio-pancreatic bypass for obesity: 1. An experimental study in dogs. Br J Surg. 1979 Sep;66(9):613-7. doi: 10.1002/bjs.1800660905.

    PMID: 497644BACKGROUND
  • Scopinaro N, Gianetta E, Civalleri D, Bonalumi U, Bachi V. Bilio-pancreatic bypass for obesity: II. Initial experience in man. Br J Surg. 1979 Sep;66(9):618-20. doi: 10.1002/bjs.1800660906.

    PMID: 497645BACKGROUND
  • Scopinaro N, Papadia F, Marinari G, et al. (2007). Biliopancreatic diversion. In Surgical Management of Obesity (pp.239-51). Philadelphia: Saunders.

    BACKGROUND
  • Scopinaro N, Marinari G, Camerini G, Papadia F; 2004 ABS Consensus Conference. Biliopancreatic diversion for obesity: state of the art. Surg Obes Relat Dis. 2005 May-Jun;1(3):317-28. doi: 10.1016/j.soard.2005.03.216. No abstract available.

    PMID: 16925242BACKGROUND
  • Scopinaro N, Marinari GM, Pretolesi F, Papadia F, Murelli F, Marini P, Adami GF. Energy and nitrogen absorption after biliopancreatic diversion. Obes Surg. 2000 Oct;10(5):436-41. doi: 10.1381/096089200321594309.

    PMID: 11054248BACKGROUND
  • Gianetta E, Friedman D, Adami GF, Vitale B, Traverso E, Castagnola M, Semino G, Scopinaro N. Etiological factors of protein malnutrition after biliopancreatic diversion. Gastroenterol Clin North Am. 1987 Sep;16(3):503-4.

    PMID: 3125106BACKGROUND
  • Ren CJ. (2004). Laparoscopic malabsorption procedures: Complications. In Laparoscopic Bariatric Surgery (pp. 343-53). Philadelphia: Lippincott Williams & Wilkins.

    BACKGROUND
  • Scopinaro N, Gianetta E, Friedman D, Adami GF, Traverso E, Vitale B, Castagnola M, Semino G, Summa M, Bachi V. Surgical revision of biliopancreatic diversion. Gastroenterol Clin North Am. 1987 Sep;16(3):529-31.

    PMID: 3436660BACKGROUND
  • Scopinaro N. Biliopancreatic diversion: mechanisms of action and long-term results. Obes Surg. 2006 Jun;16(6):683-9. doi: 10.1381/096089206777346637. No abstract available.

    PMID: 16756725BACKGROUND
  • Scopinaro N. (2008). Biliopancreatic diversion: Revisional surgery. In obesity Surgery Principles and Practice (pp.277-83). New York: McGraw Hill.

    BACKGROUND
  • Avinoah E, Ovnat A, Charuzi I. Nutritional status seven years after Roux-en-Y gastric bypass surgery. Surgery. 1992 Feb;111(2):137-42.

    PMID: 1736382BACKGROUND
  • Moize V, Geliebter A, Gluck ME, Yahav E, Lorence M, Colarusso T, Drake V, Flancbaum L. Obese patients have inadequate protein intake related to protein intolerance up to 1 year following Roux-en-Y gastric bypass. Obes Surg. 2003 Feb;13(1):23-8. doi: 10.1381/096089203321136548.

    PMID: 12630609BACKGROUND
  • Ponsky TA, Brody F, Pucci E. Alterations in gastrointestinal physiology after Roux-en-Y gastric bypass. J Am Coll Surg. 2005 Jul;201(1):125-31. doi: 10.1016/j.jamcollsurg.2005.03.021. No abstract available.

    PMID: 15978453BACKGROUND
  • Faintuch J, Matsuda M, Cruz ME, Silva MM, Teivelis MP, Garrido AB Jr, Gama-Rodrigues JJ. Severe protein-calorie malnutrition after bariatric procedures. Obes Surg. 2004 Feb;14(2):175-81. doi: 10.1381/096089204322857528.

    PMID: 15018745BACKGROUND
  • White S, Brooks E, Jurikova L, Stubbs RS. Long-term outcomes after gastric bypass. Obes Surg. 2005 Feb;15(2):155-63. doi: 10.1381/0960892053268282.

    PMID: 15802056BACKGROUND
  • Fobi MA, Lee H, Igwe D Jr, Felahy B, James E, Stanczyk M, Tambi J, Eyong P. Revision of failed gastric bypass to distal Roux-en-Y gastric bypass: a review of 65 cases. Obes Surg. 2001 Apr;11(2):190-5. doi: 10.1381/096089201321577866.

    PMID: 11355025BACKGROUND
  • Sugerman HJ, Kellum JM, DeMaria EJ. Conversion of proximal to distal gastric bypass for failed gastric bypass for superobesity. J Gastrointest Surg. 1997 Nov-Dec;1(6):517-24; discussion 524-6. doi: 10.1016/s1091-255x(97)80067-4.

    PMID: 9834387BACKGROUND
  • Kushner R. Managing the obese patient after bariatric surgery: a case report of severe malnutrition and review of the literature. JPEN J Parenter Enteral Nutr. 2000 Mar-Apr;24(2):126-32. doi: 10.1177/0148607100024002126.

    PMID: 10772194BACKGROUND
  • Mazess RB, Barden HS, Drinka PJ, Bauwens SF, Orwoll ES, Bell NH. Influence of age and body weight on spine and femur bone mineral density in U.S. white men. J Bone Miner Res. 1990 Jun;5(6):645-52. doi: 10.1002/jbmr.5650050614.

    PMID: 2382588BACKGROUND
  • Liel Y, Ulmer E, Shary J, Hollis BW, Bell NH. Low circulating vitamin D in obesity. Calcif Tissue Int. 1988 Oct;43(4):199-201. doi: 10.1007/BF02555135.

    PMID: 3145124BACKGROUND
  • Coates PS, Fernstrom JD, Fernstrom MH, Schauer PR, Greenspan SL. Gastric bypass surgery for morbid obesity leads to an increase in bone turnover and a decrease in bone mass. J Clin Endocrinol Metab. 2004 Mar;89(3):1061-5. doi: 10.1210/jc.2003-031756.

    PMID: 15001587BACKGROUND
  • Parfitt AM, Podenphant J, Villanueva AR, Frame B. Metabolic bone disease with and without osteomalacia after intestinal bypass surgery: a bone histomorphometric study. Bone. 1985;6(4):211-20. doi: 10.1016/8756-3282(85)90003-1.

    PMID: 3840379BACKGROUND
  • Van Loan MD, Johnson HL, Barbieri TF. Effect of weight loss on bone mineral content and bone mineral density in obese women. Am J Clin Nutr. 1998 Apr;67(4):734-8. doi: 10.1093/ajcn/67.4.734.

    PMID: 9537621BACKGROUND
  • Buffington C, Walker B, Cowan GS Jr, Scruggs D. Vitamin D Deficiency in the Morbidly Obese. Obes Surg. 1993 Nov;3(4):421-424. doi: 10.1381/096089293765559142.

    PMID: 10757956BACKGROUND
  • Flancbaum L, Belsley S, Drake V, Colarusso T, Tayler E. Preoperative nutritional status of patients undergoing Roux-en-Y gastric bypass for morbid obesity. J Gastrointest Surg. 2006 Jul-Aug;10(7):1033-7. doi: 10.1016/j.gassur.2006.03.004.

    PMID: 16843874BACKGROUND
  • Hamoui N, Anthone G, Crookes PF. Calcium metabolism in the morbidly obese. Obes Surg. 2004 Jan;14(1):9-12. doi: 10.1381/096089204772787211.

    PMID: 14980026BACKGROUND
  • Ybarra J, Sanchez-Hernandez J, Gich I, De Leiva A, Rius X, Rodriguez-Espinosa J, Perez A. Unchanged hypovitaminosis D and secondary hyperparathyroidism in morbid obesity after bariatric surgery. Obes Surg. 2005 Mar;15(3):330-5. doi: 10.1381/0960892053576758.

    PMID: 15826464BACKGROUND
  • Chapin BL, LeMar HJ Jr, Knodel DH, Carter PL. Secondary hyperparathyroidism following biliopancreatic diversion. Arch Surg. 1996 Oct;131(10):1048-52; discussion 1053. doi: 10.1001/archsurg.1996.01430220042009.

    PMID: 8857901BACKGROUND
  • Bell NH, Greene A, Epstein S, Oexmann MJ, Shaw S, Shary J. Evidence for alteration of the vitamin D-endocrine system in blacks. J Clin Invest. 1985 Aug;76(2):470-3. doi: 10.1172/JCI111995.

    PMID: 3839801BACKGROUND
  • Compston JE, Vedi S, Ledger JE, Webb A, Gazet JC, Pilkington TR. Vitamin D status and bone histomorphometry in gross obesity. Am J Clin Nutr. 1981 Nov;34(11):2359-63. doi: 10.1093/ajcn/34.11.2359.

    PMID: 7304477BACKGROUND
  • Hey H, Stokholm KH, Lund B, Lund B, Sorensen OH. Vitamin D deficiency in obese patients and changes in circulating vitamin D metabolites following jejunoileal bypass. Int J Obes. 1982;6(5):473-9.

    PMID: 6983505BACKGROUND
  • Riedt CS, Brolin RE, Sherrell RM, Field MP, Shapses SA. True fractional calcium absorption is decreased after Roux-en-Y gastric bypass surgery. Obesity (Silver Spring). 2006 Nov;14(11):1940-8. doi: 10.1038/oby.2006.226.

    PMID: 17135609BACKGROUND
  • Johnson JM, Maher JW, DeMaria EJ, Downs RW, Wolfe LG, Kellum JM. The long-term effects of gastric bypass on vitamin D metabolism. Ann Surg. 2006 May;243(5):701-4; discussion 704-5. doi: 10.1097/01.sla.0000216773.47825.c1.

    PMID: 16633006BACKGROUND
  • Allied Health Sciences Section Ad Hoc Nutrition Committee; Aills L, Blankenship J, Buffington C, Furtado M, Parrott J. ASMBS Allied Health Nutritional Guidelines for the Surgical Weight Loss Patient. Surg Obes Relat Dis. 2008 Sep-Oct;4(5 Suppl):S73-108. doi: 10.1016/j.soard.2008.03.002. Epub 2008 May 19. No abstract available.

    PMID: 18490202BACKGROUND
  • Brolin RE, Gorman RC, Milgrim LM, Kenler HA. Multivitamin prophylaxis in prevention of post-gastric bypass vitamin and mineral deficiencies. Int J Obes. 1991 Oct;15(10):661-7.

    PMID: 1752727BACKGROUND
  • Goode LR, Brolin RE, Chowdhury HA, Shapses SA. Bone and gastric bypass surgery: effects of dietary calcium and vitamin D. Obes Res. 2004 Jan;12(1):40-7. doi: 10.1038/oby.2004.7.

    PMID: 14742841BACKGROUND
  • Johnson JM, Maher JW, Samuel I, Heitshusen D, Doherty C, Downs RW. Effects of gastric bypass procedures on bone mineral density, calcium, parathyroid hormone, and vitamin D. J Gastrointest Surg. 2005 Nov;9(8):1106-10; discussion 1110-1. doi: 10.1016/j.gassur.2005.07.012.

    PMID: 16269381BACKGROUND
  • Youssef Y, Richards WO, Sekhar N, Kaiser J, Spagnoli A, Abumrad N, Torquati A. Risk of secondary hyperparathyroidism after laparoscopic gastric bypass surgery in obese women. Surg Endosc. 2007 Aug;21(8):1393-6. doi: 10.1007/s00464-007-9228-6. Epub 2007 Feb 21.

    PMID: 17318692BACKGROUND
  • Marceau P, Biron S, Lebel S, Marceau S, Hould FS, Simard S, Dumont M, Fitzpatrick LA. Does bone change after biliopancreatic diversion? J Gastrointest Surg. 2002 Sep-Oct;6(5):690-8. doi: 10.1016/s1091-255x(01)00086-5.

    PMID: 12399058BACKGROUND
  • Hamoui N, Kim K, Anthone G, Crookes PF. The significance of elevated levels of parathyroid hormone in patients with morbid obesity before and after bariatric surgery. Arch Surg. 2003 Aug;138(8):891-7. doi: 10.1001/archsurg.138.8.891.

    PMID: 12912749BACKGROUND
  • Newbury L, Dolan K, Hatzifotis M, Low N, Fielding G. Calcium and vitamin D depletion and elevated parathyroid hormone following biliopancreatic diversion. Obes Surg. 2003 Dec;13(6):893-5. doi: 10.1381/096089203322618722.

    PMID: 14738677BACKGROUND
  • Slater GH, Ren CJ, Siegel N, Williams T, Barr D, Wolfe B, Dolan K, Fielding GA. Serum fat-soluble vitamin deficiency and abnormal calcium metabolism after malabsorptive bariatric surgery. J Gastrointest Surg. 2004 Jan;8(1):48-55; discussion 54-5. doi: 10.1016/j.gassur.2003.09.020.

    PMID: 14746835BACKGROUND
  • Dolan K, Hatzifotis M, Newbury L, Fielding G. A comparison of laparoscopic adjustable gastric banding and biliopancreatic diversion in superobesity. Obes Surg. 2004 Feb;14(2):165-9. doi: 10.1381/096089204322857500.

    PMID: 15018743BACKGROUND
  • DeMaria EJ. Is gastric bypass superior for the surgical treatment of obesity compared with malabsorptive procedures? J Gastrointest Surg. 2004 May-Jun;8(4):401-3. doi: 10.1016/j.gassur.2003.12.022. No abstract available.

    PMID: 15120361BACKGROUND
  • Dolan K, Hatzifotis M, Newbury L, Lowe N, Fielding G. A clinical and nutritional comparison of biliopancreatic diversion with and without duodenal switch. Ann Surg. 2004 Jul;240(1):51-6. doi: 10.1097/01.sla.0000129280.68540.76.

    PMID: 15213618BACKGROUND
  • Brolin RE, Gorman JH, Gorman RC, Petschenik AJ, Bradley LB, Kenler HA, Cody RP. Prophylactic iron supplementation after Roux-en-Y gastric bypass: a prospective, double-blind, randomized study. Arch Surg. 1998 Jul;133(7):740-4. doi: 10.1001/archsurg.133.7.740.

    PMID: 9688002BACKGROUND
  • Brolin RE, LaMarca LB, Kenler HA, Cody RP. Malabsorptive gastric bypass in patients with superobesity. J Gastrointest Surg. 2002 Mar-Apr;6(2):195-203; discussion 204-5. doi: 10.1016/s1091-255x(01)00022-1.

    PMID: 11992805BACKGROUND
  • Marceau P, Hould FS, Lebel S, Marceau S, Biron S. Malabsorptive obesity surgery. Surg Clin North Am. 2001 Oct;81(5):1113-27. doi: 10.1016/s0039-6109(05)70187-0.

    PMID: 11589248BACKGROUND
  • Brolin RE, Gorman JH, Gorman RC, Petschenik AJ, Bradley LJ, Kenler HA, Cody RP. Are vitamin B12 and folate deficiency clinically important after roux-en-Y gastric bypass? J Gastrointest Surg. 1998 Sep-Oct;2(5):436-42. doi: 10.1016/s1091-255x(98)80034-6.

    PMID: 9843603BACKGROUND
  • Halverson JD. Micronutrient deficiencies after gastric bypass for morbid obesity. Am Surg. 1986 Nov;52(11):594-8.

    PMID: 3777703BACKGROUND
  • Marcuard SP, Sinar DR, Swanson MS, Silverman JF, Levine JS. Absence of luminal intrinsic factor after gastric bypass surgery for morbid obesity. Dig Dis Sci. 1989 Aug;34(8):1238-42. doi: 10.1007/BF01537272.

    PMID: 2666054BACKGROUND
  • Skroubis G, Sakellaropoulos G, Pouggouras K, Mead N, Nikiforidis G, Kalfarentzos F. Comparison of nutritional deficiencies after Roux-en-Y gastric bypass and after biliopancreatic diversion with Roux-en-Y gastric bypass. Obes Surg. 2002 Aug;12(4):551-8. doi: 10.1381/096089202762252334.

    PMID: 12194550BACKGROUND
  • Rhode BM, Tamin H, Gilfix BM, Sampalis JS, Nohr C, MacLean LD. Treatment of Vitamin B12 Deficiency after Gastric Surgery for Severe Obesity. Obes Surg. 1995 May;5(2):154-158. doi: 10.1381/096089295765557953.

    PMID: 10733805BACKGROUND
  • Ocon Breton J, Perez Naranjo S, Gimeno Laborda S, Benito Ruesca P, Garcia Hernandez R. [Effectiveness and complications of bariatric surgery in the treatment of morbid obesity]. Nutr Hosp. 2005 Nov-Dec;20(6):409-14. Spanish.

    PMID: 16335025BACKGROUND
  • Boylan LM, Sugerman HJ, Driskell JA. Vitamin E, vitamin B-6, vitamin B-12, and folate status of gastric bypass surgery patients. J Am Diet Assoc. 1988 May;88(5):579-85.

    PMID: 3367015BACKGROUND
  • Mechanick JI, Kushner RF, Sugerman HJ, Gonzalez-Campoy JM, Collazo-Clavell ML, Guven S, Spitz AF, Apovian CM, Livingston EH, Brolin R, Sarwer DB, Anderson WA, Dixon J. American Association of Clinical Endocrinologists, The Obesity Society, and American Society for Metabolic & Bariatric Surgery Medical Guidelines for Clinical Practice for the perioperative nutritional, metabolic, and nonsurgical support of the bariatric surgery patient. Surg Obes Relat Dis. 2008 Sep-Oct;4(5 Suppl):S109-84. doi: 10.1016/j.soard.2008.08.009. Epub 2008 Aug 19.

    PMID: 18848315BACKGROUND

Related Links

MeSH Terms

Conditions

KwashiorkorBone Diseases, Metabolic

Condition Hierarchy (Ancestors)

Severe Acute MalnutritionMalnutritionNutrition DisordersNutritional and Metabolic DiseasesBone DiseasesMusculoskeletal DiseasesMetabolic Diseases

Study Officials

  • Francisco M Tercero, MD

    Research Associate, University of California San Francisco

    STUDY DIRECTOR
  • Kelvin D Higa, MD

    Professor of Surgery, University of California San Francisco

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
RETROSPECTIVE
Sponsor Type
OTHER

Study Record Dates

First Submitted

December 26, 2009

First Posted

December 31, 2009

Study Start

March 1, 2009

Primary Completion

August 1, 2009

Study Completion

October 1, 2009

Last Updated

January 1, 2010

Record last verified: 2009-12

Locations